Glucose Variability vs HbA1c for Non-Diabetics: Why Your Average Misses the Story

Your Blood Sugar Isn't What You Think It Is

Imagine two people with identical HbA1c levels of 5.4%. Person A maintains steady glucose between 85-110 mg/dL throughout the day. Person B swings from 65 to 180 mg/dL after every meal, but averages out to the same number. Their lab reports look identical. Their metabolic realities couldn't be more different.

This is the basic limitation of HbA1c for anyone without diabetes who wants to understand their metabolic health. It's like judging a roller coaster and a flat highway by their average elevation. Technically accurate, but it tells you nothing about the ride.

Research with continuous glucose monitors (CGMs) has made that limitation visible. The PREDICT 1 study, published in Nature Medicine in 2020, measured post-meal responses in 1,002 healthy adults in the UK, including twins, and found large differences between people eating identical meals. What it did not show is that variability predicts disease better than HbA1c—that question is still open.

What HbA1c Actually Measures (And What It Misses)

HbA1c reflects the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them. Since red blood cells live about 90-120 days, this gives you a weighted average of your blood sugar over roughly three months. Higher sustained glucose means more glycated hemoglobin.

For managing diabetes, this metric revolutionized care. It gave doctors and patients a reliable number that couldn't be gamed by eating well the week before a fasting glucose test.

But here's what HbA1c fundamentally cannot tell you:

• How high your glucose spikes after meals
• How low it drops between meals or during sleep
• How quickly your body returns to baseline after eating
• Whether your glucose pattern looks like gentle rolling hills or jagged mountain peaks

Studies with CGMs show how much average-based tests can hide. In the Stanford "glucotypes" study (PLOS Biology, 2018), even some people classed as normoglycemic by standard tests showed high variability on CGM, with glucose reaching the prediabetic range about 15% of the time and the diabetic range about 2% of the time.

Glucose Variability Metrics That Actually Matter

There is no official CGM target for people without diabetes. The best reference point is a 2019 multicenter study that fitted 153 healthy, non-obese children and adults with a blinded Dexcom G6 sensor to describe what normal looks like. International consensus targets exist, but they were written for people with diabetes.

Coefficient of Variation (CV%) calculates how much your glucose fluctuates relative to your mean. In the healthy reference study, the average within-person CV was 17% ± 3%. For people with diabetes, international consensus treats a CV of 36% or less as stable glucose.

Time in Range (TIR) measures what percentage of the day your glucose stays within target bounds. Healthy participants spent a median of 96% of the day between 70 and 140 mg/dL (interquartile range 93-98%). For diabetes, the consensus target is different: more than 70% of the time between 70 and 180 mg/dL.

Mean Amplitude of Glycemic Excursions (MAGE) captures the average size of your significant glucose swings throughout the day. Lower is generally better—think gentle waves rather than tsunami-sized spikes.

Brief rises are normal. In the same healthy group, median time above 140 mg/dL was 2.1% of the day (about 30 minutes), and median time below 70 mg/dL was 1.1% (about 15 minutes). Mean glucose was 98-99 mg/dL in most age groups and slightly higher (104 mg/dL) in people over 60.

What the PREDICT Study Found

Tim Spector's ZOE PREDICT research did something unprecedented. Rather than studying people with diabetes, the team recruited healthy adults and tracked their glucose responses to standardized meals using continuous monitors.

The findings challenged one-size-fits-all advice. Post-meal glucose responses to identical meals varied widely between people, and identical twins often responded differently; genetic variants added only modestly to predictions. An earlier Israeli study of 800 people (Cell, 2015) found the same high variability in responses to identical meals and used it to build personalized diet predictions.

What PREDICT did not show is just as important. It measured short-term responses to test meals; it was not designed to prove that people with bigger swings go on to develop more visceral fat, inflammation or heart disease.

So for people without diabetes, the honest summary is this: how your glucose moves is highly individual and interesting to observe, but whether variability matters more than your average for long-term health has not yet been proven.

Why Spikes Might Matter

Why might spikes matter at all? Laboratory studies suggest that rapid glucose rises increase oxidative stress, and cells appear to cope better with stable levels than with repeated swings.

In a 2008 clamp study in Diabetes that included healthy volunteers as well as people with type 2 diabetes, glucose oscillating between about 90 and 270 mg/dL (5-15 mmol/L) every six hours impaired blood-vessel lining (endothelial) function and raised oxidative stress markers more than constantly high glucose did. This was an artificial, extreme experiment, not everyday eating, but it is one reason researchers take variability seriously.

Think of it like exercise. Gradual increases in heart rate during a jog are healthy stress. Sudden spikes from zero to maximum repeatedly throughout the day would damage your cardiovascular system. Glucose works similarly.

Because responses to the same food differ so much, one person's rice spike may be another person's gentle bump. A one-off high reading after a large carbohydrate-heavy meal isn't a diagnosis. Fasting glucose or HbA1c in the prediabetes range (HbA1c 5.7-6.4%) is what warrants a conversation with your doctor.

Practical Implications for Non-Diabetics

If you're considering wearing a CGM for health optimization rather than diabetes management, focus on these metrics rather than chasing a lower average glucose:

Look at your CV% over about two weeks. In healthy adults it averages around 17%. If yours is consistently well above that, look at which meals, sleep patterns or stressful days line up with your biggest swings.

Check your time above 140 mg/dL. There is no official limit for people without diabetes, but healthy participants in the reference study spent a median of about 2% of the day (roughly 30 minutes) above it. If specific meals keep you there for long stretches, you've found something worth adjusting.

Pay attention to overnight patterns. Glucose is usually fairly stable during sleep in healthy people. Large overnight swings can reflect late meals or alcohol, and apparent lows can also be sensor artifacts from lying on the sensor.

Simple habits can blunt post-meal rises. A 2022 meta-analysis found that breaking up prolonged sitting with light walking significantly reduced post-meal glucose and insulin compared with sitting still. Whether these short-term improvements change long-term health in people without diabetes hasn't been tested.

The Limitations of Variability Metrics

This isn't a case for abandoning HbA1c entirely. The metric remains valuable for screening, for tracking diabetes management, and for population-level health assessment. Insurance covers it. Doctors understand it. It's standardized across labs worldwide.

Glucose variability metrics from CGMs have their own issues. Sensor accuracy varies—most consumer CGMs have a mean absolute relative difference (MARD) of 9-11%, meaning readings can be off by that percentage. A reading of 140 mg/dL might actually be 126 or 154.

Day-to-day variation is normal and expected. Stressing over every spike defeats the purpose, and researchers caution against over-interpreting a single day of data in people without diabetes.

And we don't yet have long-term outcome studies proving that reducing glucose variability in healthy people prevents disease. The associations are strong. The biological mechanisms are plausible. The randomized controlled trials proving causation don't exist yet.

A More Complete Picture

The future of metabolic health assessment probably isn't HbA1c versus glucose variability. It's both, interpreted together.

HbA1c tells you your average exposure. Variability metrics tell you the pattern of that exposure. Combined with fasting insulin, lipid panels, and inflammatory markers, you get a multidimensional view of metabolic health that no single number can provide.

For people without diabetes who are curious about their metabolism, CGM data can show how individual their responses are. Variability is worth understanding, but it hasn't been shown to deserve more weight than proven markers like HbA1c, fasting glucose, blood pressure and lipids.

The roller coaster and the highway may share an average elevation. A CGM can show you which ride you're on; your doctor can help you decide whether it matters.